Expanded Access for Apixaban
Purpose
This is an expanded access designed to provide access to apixaban for eligible participants.
Eligibility
- Eligible Ages
- Between 28 Days and 17 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Pediatric patients with Congenital or Acquired Heart Disease Requiring Chronic Anticoagulation for Thromboembolism Prevention - Previously participated in the CV185-362 study and was on apixaban for 1 year or until treatment was no longer required
Exclusion Criteria
- Weight less than 5 kg or greater than 35 kg Other inclusion/exclusion criteria apply
Study Design
- Phase
- Study Type
- Expanded Access
Recruiting Locations
Childrens Hospital Of Philadelphia
Philadelphia, Pennsylvania 19104
Philadelphia, Pennsylvania 19104
Contact:
Andrew Glatz, Site 0001
Andrew Glatz, Site 0001
More Details
- Status
- Available
- Sponsor
- Bristol-Myers Squibb
Study Contact
Recruiting sites have contact information. Please contact the sites directly. If there is no contact information,please email:
Clinical.Trials@bms.com